Catchtrial eConsent - 2026 Pricing, Features, Reviews & Alternatives

Catchtrial Apps+ is an integrated digital clinical trial data capture platform that encompasses electronic patient-reported outcomes, electronic clinical outcome assessments and electronic consent capabilities for clinical research organizations, pharmaceutical companies, contract research organizations and academic research centers conducting clinical trials. The platform replaces paper documentation and fragmented digital tools with a secure, unified ecosystem that enables patients and clinicians to capture outcome data from any location using any device.

The ePRO module delivers health status surveys directly to patients through an intuitive interface, capturing symptoms, diaries and quality-of-life data in real time with full integration into electronic data capture systems for immediate desktop access without manual reentry. The built-in forms builder provides a no-code interface for study teams to design and deploy patient questionnaires without programming expertise, while the integrated eDiary feature automates routine data capture on daily, weekly or monthly schedules. Patient registration is handled via secure QR code technology that avoids collection of participants’ sensitive data and maintains compliance with GDPR, HIPAA and regulatory requirements including ICH/GCP and twenty-one CFR Part eleven standards.

The eCOA module supports multi-stakeholder outcome data capture through a modular configuration system that offers customized applications with guided workflows for standardized assessments. Automated scoring and calculations are performed within the application to reduce variability and eliminate manual errors, and multilanguage support enables global instrument deployment. The eConsent capability leverages telemedicine-inspired technology to facilitate remote and on-site consent processes on Android and iOS devices, guiding participants through study information with quizzed consent functionality and assessing comprehension before signature collection. Pre-screening surveys evaluate participant eligibility to reduce screen failures, while e-signatures are supported by multi-factor authentication and biometric verification within a complete audit trail.

The platform maintains a privacy-first architecture that does not collect participants’ sensitive data and implements end-to-end data tracking to support inspection-readiness across global regulatory frameworks. Investigators access training resources and on-demand recordings to ensure consistency across sites, and centralized interfaces enable one-click exports for rapid review, monitoring and analysis. API-based data exchange facilitates integration with the broader trial management ecosystem, including electronic data capture systems and investigator training platforms, to support decentralized workflows and unified trial oversight.